Active Not Recruiting NA INTERVENTIONAL 1-arm NCT06087718

Feasibility of the Maastro Applicator in Rectal Cancer

Introduction of the Maastro Applicator for Endoluminal Boosting in Rectal Cancer: a Pilot Study

Sponsor: Maastricht Radiation Oncology

Conditions Brachytherapy Complete Response Feasibility Quality of Life Radiation Proctitis Radiation Toxicity Rectal Cancer Toxicity

Interventions Maastro applicator

Updated 5 times since 2023 Last updated: Aug 11, 2025 Started: Aug 27, 2024 Primary completion: Apr 30, 2026 Completion: Apr 30, 2031

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Brachytherapy and Complete Response, this trial is ongoing. The trial is conducted by Maastricht Radiation Oncology and has accumulated 5 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Active Not Recruiting NA

Status: Not Yet Recruiting → Active Not Recruiting
Sep 2024 — Sep 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA
Nov 2023 — Jun 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht Radiation Oncology
Varian Medical Systems

Data source: Maastricht Radiation Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands